(2026) -
Chronological (971 items)
(All links open in new tab)
| Jun 20, 2026 |
Vermont Governor Signs Bill To Double Legal Marijuana Possession Limit And Allow Interstate Commerce
Vermont’s governor has signed legislation that will allow adults over the age of 21 to legally possess twice as much marijuana as they could previously, enable interstate cannabis commerce and make other changes to rules for licensed businesses. Gov. Phil Scott (R) on Friday announced that he approved the large-scale cannabis regulatory reform bill, S. 278, which passed both chambers of the legislature last month. |
|---|---|
| Jun 20, 2026 |
Regulated, Untamed, and Built to Last: Inside Montana Cannabis
How Montana built a legal cannabis market from a thin medical marijuana law, federal raids, ballot fights, and two decades of stubborn local pressure. |
| Jun 19, 2026 |
Health officials warn visitors that cannabis in Washington can be stronger than in other parts of US
WASHINGTON — The Washington Department of Health is warning FIFA visitors about the strength of cannabis in Washington. The state health agency says potency varies by product and recommends that users start with a low dose and go slow. The Washington DoH posted the recommendation on its Facebook page on Friday, along with a claim that it has seen an uptick in cannabis-related emergency room visits. |
| Jun 19, 2026 |
April 2026 Cannabis Sales Data: Regional Trends and National Growth
Cannabis sales in Canada in April 2026 were $482.6 million, according to the latest figures from Statistics Canada. While cannabis sales have been showing signs of slowing, compared to exponential growth in the first few years of legalization, sales were still up 3% from April 2025 and up 5% from the previous month’s $466.8 million. Statistics Canada also updated its March 2026 sales figures, which were previously reported as $471.4 million. The country’s national statistical agency routinely adjusts these sales figures as new data comes in. Year-over-year and month-over-month increases were seen in every province except Newfoundland and Labrador, which showed a 2% decline compared to March, and Manitoba, which showed a decline of less than 1% MOM. Sales figures for the Northwest Territories and Nunavut were not available. |
| Jun 19, 2026 |
Cannabis Tax Revenue Hits $28 Billion Since First Legalization
States that have legalized recreational cannabis have collected more than $28 billion in tax revenue over the past roughly 12 years, according to a new report from the cannabis policy reform group Marijuana Policy Project. |
| Jun 19, 2026 |
Health Canada Orders Ontario Cannabis Store to Remove Colourful Mural
Health Canada has told a cannabis retailer about two hours north of Toronto that it must remove a large, colourful mural from the outside of its building. Treetz Cannabis, an independently run store in the community of Collingwood, had an artist paint a mural on the outside. The mural includes various characters painted in bright colours. |
| Jun 19, 2026 |
Fewer Colorado Teens Are Using Marijuana Now Than Before Legalization, State Study Shows, Refuting Opponents’ Core Argument
Rates of marijuana use among Colorado teens continued to decline in 2025—and youth are also reporting significantly lower levels of access to cannabis—according to a biennial survey from state health officials. |
| Jun 19, 2026 |
The Power of Patient Stories: How Lived Experience is Shifting Medical Cannabis Stigma
Despite medical cannabis being legal in the UK for almost eight years, many patients remain hesitant or unsure about whether it is right for them. While awareness of the legality and legitimacy of the medicinal use of cannabis has improved since 2018, misconceptions and stigma continue to shape public perceptions. Even though cannabis-based products for medicinal use are prescribed under a tightly regulated framework in the UK, many people still associate it primarily with recreational use. |
| Jun 19, 2026 |
How Cannabis Went Mainstream In Modern Culture
Cannabis used to live on the edges of the culture. Now it sits near the center, in the music, the lifestyle content, and the everyday routines of millions of adults. The shift was gradual, then sudden. A generation that grew up online watched the old stigma quietly fall away. Part of that change is simply access. The rise of services that let someone find a Kush Delivery Near Me Now and order from the couch made cannabis feel ordinary, not illicit. Vancouver operators shipping across Canada helped set that pace. This piece looks at how cannabis went mainstream, and what that means for the people buying it. |
| Jun 19, 2026 |
DEA Names 7 Anti-Rescheduling Parties for Cannabis Hearing, Zero Pro Parties
Those who thought the Drug Enforcement Administration (DEA) stacked the cannabis rescheduling deck in favor of prohibitionists under the Joe Biden administration may be in for more disappointment. Under a new administrative law judge hearing process that’s scheduled to begin June 29 – for the DEA to determine the merits of a proposed rule to reclassify cannabis as a Schedule III drug under the Controlled Substances Act (CSA) – President Donald Trump’s administration will only entertain testimony from those who oppose the proposed rule. |
| Jun 19, 2026 |
In the cannabis industry, ‘culture’ is revealed in hard times
Cannabis companies are eager - sometimes desperate - to show authentic "cannabis culture." But companies create and maintain culture through consistent actions, our columnist argues. |
| Jun 18, 2026 |
High Doses of CBD Superior to Placebo in Treating Neuropathic Pain
Sydney, Australia: The daily use of CBD is safe and effective for treating chronic neuropathic pain, according to placebo-controlled clinical trial data published in the journal eClinical Medicine. Australian researchers assessed the consumption of oral THC versus a placebo among a cohort of 38 patients with spinal cord-related neuropathy. Study participants receiving the intervention used increasingly higher doses of oral CBD throughout the trial, with patients consuming 800 milligrams of CBD daily for the final four weeks of the study. Patients’ pain levels were assessed one week prior to the start of the trial and again at the conclusion of the study. |
| Jun 18, 2026 |
Study Shows Marijuana Extracts Notably Improve Symptoms of Cancer Patients
A new clinical study indicates that cannabis-derived medicinal extracts may help reduce several symptoms associated with cancer, including difficulty sleeping and anxiety, though patient responses varied considerably depending on which cannabinoid profile worked best for each individual. The study team evaluated oil-based formulations with different proportions of cannabidiol (CBD) and tetrahydrocannabinol (THC) using a randomized, placebo-controlled trial that was triple-blinded to reduce bias. Overall results suggest that cannabis oil treatments produced meaningful relief in about half of participants, with improvements most often reported in sleep-related issues and closely connected symptoms. When outcomes were averaged across the study population, no single formulation consistently showed superior performance compared with the others. |
| Jun 18, 2026 |
Medical Cannabis in France: What the First Major Study Reveals About Its Actual Impact
Four years after the launch of the national pilot program, a study commissioned by the ANSM finally provides concrete data on the effect of medical cannabis on treatments and the care pathways of French patients. The results, published in September 2025 by the AHeaD team at the Inserm Research Center at the University of Bordeaux and obtained by the Union of Industrialists for the Promotion of Hemp Extracts (UIVEC) following a CADA request, are encouraging. |
| Jun 18, 2026 |
Minnesota cannabis store owners lament testing backlog: "It's getting frustrating for everyone involved"
One of five cannabis testing sites in Minnesota is shutting down, citing exorbitant costs as the reason. William Drexler is moving product he has around as he waits patiently for more. He says customers who come into Grey Area, on Grand Avenue in St. Paul, are looking for adult-use items, which he says are being held up by a backlog in testing. |
| Jun 18, 2026 |
Massachusetts caps cannabis cultivation, expands retail
Massachusetts cannabis regulators recently moved in two directions at once, freezing one part of the market while opening another. As of June 16, the state Cannabis Control Commission has temporarily stopped accepting new applications for marijuana cultivation licenses, according to an agency bulletin. With an estimated 1 square foot to 1.2 square feet of licensed canopy per adult age 21 or older, Massachusetts has significantly more cultivation capacity per capita than nearby Connecticut, where prices are higher, according to the CCC. |
| Jun 18, 2026 |
Cannabis Stocks Pop As Another U.S. Company Applies to List on NYSE
That was fast: California cannabis company Glass House Brands on Wednesday applied to become the second U.S. cannabis firm to list on the NYSE, following the path laid by competitor Trulieve last week. Glass House stock popped about 5% on Thursday and is up about 52% since January 1. Trulieve stock rose about 5% and is up about 16% this year. The AdvisorShares Pure Cannabis ETF (MSOS) is up 4% Thursday and about 4% since January 1, though still about 90% below its 2021 all-time high. |
| Jun 18, 2026 |
Union Warns of Possible Ontario Cannabis Store Labour Action as Negotiations Continue
The labour union representing some workers at the Ontario Cannabis Store (OCS) is warning cannabis retailers across the province of a potential labour disruption that the union says could affect services. In a letter sent to cannabis retailers on June 15, 2026, the Ontario Public Service Employees Union (OPSEU/SEFPO) warns of ongoing negotiations and a possible labour disruption if union demands are not met following a final bargaining session with the OCS on June 22. The union represents approximately 200,000 members across Ontario, including employees at the OCS. |
| Jun 18, 2026 |
Plant-Derived Cannabis Formula Granted ‘Breakthrough’ Designation by FDA for Pain Treatment
Regulators at the US Food and Drug Administration have granted ‘Breakthrough Therapy Designation’ to a proprietary cannabis extract (VER-01) containing 2.5 milligrams of THC and standardized percentages of CBD and CBG (cannabigerol). A press release issued by the product’s manufacturer, VERTANICAL, states that the designation “is intended to expedite the development and review of investigational medicines where preliminary clinical evidence indicates the potential for substantial improvement over available therapies.†The FDA’s decision follows the results of a Phase 3 clinical trial concluding that patients who consumed the cannabis extract experienced greater mean pain reduction than did those taking opioids. |
| Jun 18, 2026 |
Supreme Court Upholds Marijuana Users’ Gun Rights, Rejecting Trump DOJ Arguments In Major Second Amendment Case
The U.S. Supreme Court has unanimously sided with a man who was prosecuted for possessing a gun while being a regular consumer of marijuana, ruling that the government’s actions violate the Second Amendment. The opinion authored by Justice Neil Gorsuch is narrow in scope and does not entirely strike down the federal law known as 922(g)(3) that prohibits people who illegally consume controlled substances from possessing or purchasing firearms. |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49